TISSIUM reposted this
Founder, now Advisor, LSX Ltd., Founder Holoday™, Private Investor and Founding Member, Events Venture Group
The 2023 European Lifestars Awards - Celebrating Life Science eXecutives & their partners finalists have been released. Who has made the Late Stage Venture Round / Series C+ Finance Raise Of the Year category roster? Congratulations to Alentis Therapeutics Amolyt Pharma Aphea.Bio Apollo Therapeutics CatalYm GmbH Crescendo Biologics Limited Minervax ApS Syntach AB TISSIUM Xeltis These 10 companies and their executives will be contesting this years Series C+ Finance Raise of the Year, looking to secure a podium place or outright winners’ trophy, plus earn points for their EU region, helping contribute to the overall Region of the Year award. Ticket and table sales are now open to join this years finalists and hundreds of their support network at the not-to-be missed 5hr evening extravaganza on 13th November at London’s prestigious Honourable Artillery Company venue. For the full 130+ finalist roster across all categories and details on how to attend the hottest ticket in town this November, visit https://lnkd.in/eJbxSHu
